Bancel Stephane
SEC insider (Form 3/4/5 filer). CIK 0001443340. Chief Executive Officer at Moderna, Inc. (MRNA) and 1 other issuer. 17 reported Form 4/5 transactions since Sep 2024; latest on Aug 6, 2026. Located in CAMBRIDGE, MA.
Companies Bancel Stephane has filed insider reports for
- Moderna, Inc. (MRNA): Director, Officer, Chief Executive Officer
- Generate Biomedicines, Inc. (GENB): Director
Bancel Stephane
CIK: 0001443340
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Aug 6, 2026MRNA
Moderna, Inc.
ExerciseDirect252.5K shares at avg. $19.15$4.8M - Aug 5, 2026MRNA
Moderna, Inc.
ExerciseDirect499.2K shares at avg. $19.15$9.6M - Aug 5, 2026MRNA
Moderna, Inc.
SaleDirect147.5K shares at avg. $56.21$8.3M - Aug 5, 2026MRNA
Moderna, Inc.
SaleDirect124.8K shares at avg. $56.96$7.1M - Aug 5, 2026MRNA
Moderna, Inc.
SaleDirect39.9K shares at avg. $58.12$2.3M - Aug 5, 2026MRNA
Moderna, Inc.
SaleDirect187K shares at avg. $58.79$11.0M - Mar 2, 2026GENB
Generate Biomedicines, Inc.
ConversionIndirect724.2K shares- - Mar 1, 2026MRNA
Moderna, Inc.
AwardDirectStock Option (Right to Buy)
250.9K shares- - Feb 26, 2026GENB
Generate Biomedicines, Inc.
AwardDirectStock Option (Right to Buy)
29.6K shares- - Feb 11, 2026MRNA
Moderna, Inc.
Tax PaymentDirect5.5K shares at avg. $41.99$229K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 6, 2026 |  MRNA Moderna, Inc. | Exercise | 252,469 | $19.15 | $4,834,781 | Direct |
| Aug 5, 2026 | MRNA Moderna, Inc. | Exercise | 499,246 | $19.15 | $9,560,561 | Direct |
| Aug 5, 2026 | MRNA Moderna, Inc. | Sale | 147,473 | $56.21 | $8,289,457 | Direct |
| Aug 5, 2026 | MRNA Moderna, Inc. | Sale | 124,838 | $56.96 | $7,110,772 | Direct |
| Aug 5, 2026 | MRNA Moderna, Inc. | Sale | 39,891 | $58.12 | $2,318,465 | Direct |
| Aug 5, 2026 | MRNA Moderna, Inc. | Sale | 187,044 | $58.79 | $10,996,317 | Direct |
| Mar 2, 2026 |  GENB Generate Biomedicines, Inc. | Conversion | 724,160 | - | $0 | Indirect |
| Mar 1, 2026 | MRNA Moderna, Inc. | Award Stock Option (Right to Buy) | 250,932 | - | - | Direct |
| Feb 26, 2026 | GENB Generate Biomedicines, Inc. | Award Stock Option (Right to Buy) | 29,561 | - | - | Direct |
| Feb 11, 2026 | MRNA Moderna, Inc. | Tax Payment | 5,450 | $41.99 | $228,846 | Direct |
1-10 of 17 transactions